<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-vaccines-07-00174">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Heldens</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Pouwels</surname>
    <given-names>H.G.</given-names>
   </name>
   <name>
    <surname>Derks</surname>
    <given-names>C.G.</given-names>
   </name>
   <name>
    <surname>Van de Zande</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Hoeijmakers</surname>
    <given-names>M.J.</given-names>
   </name>
  </person-group>
  <article-title>The first safe inactivated equine influenza vaccine formulation adjuvanted with iscom-matrix that closes the immunity gap</article-title>
  <source>Vaccine</source>
  <year>2009</year>
  <volume>27</volume>
  <fpage>5530</fpage>
  <lpage>5537</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.06.085</pub-id>
  <pub-id pub-id-type="pmid">19607950</pub-id>
 </element-citation>
</ref>
